| 000 | 01475 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517054132.0 | ||
| 264 | 0 | _c20160927 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1471-4973 | ||
| 024 | 7 |
_a10.1016/j.coph.2015.09.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcCarville, Justin L | |
| 245 | 0 | 0 |
_aPharmacological approaches in celiac disease. _h[electronic resource] |
| 260 |
_bCurrent opinion in pharmacology _cDec 2015 |
||
| 300 |
_a7-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAncylostomatoidea |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCeliac Disease _xdiet therapy |
| 650 | 0 | 4 | _aDiet, Gluten-Free |
| 650 | 0 | 4 |
_aElafin _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Therapy _xmethods |
| 650 | 0 | 4 |
_aGTP-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGlutens _xadverse effects |
| 650 | 0 | 4 |
_aHLA Antigens _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aProbiotics _xtherapeutic use |
| 650 | 0 | 4 | _aProtein Glutamine gamma Glutamyltransferase 2 |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aTransglutaminases _xantagonists & inhibitors |
| 700 | 1 | _aCaminero, Alberto | |
| 700 | 1 | _aVerdu, Elena F | |
| 773 | 0 |
_tCurrent opinion in pharmacology _gvol. 25 _gp. 7-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.coph.2015.09.002 _zAvailable from publisher's website |
| 999 |
_c25304003 _d25304003 |
||